ARCHIVES

NRC Group Splits Over chemical Dose Testing For Carcinogenicity

This article is from The Cancer Letter archive.

Vol. 19 No. 11 | March 12, 1993

Download PDF Visit The Full Archive

Related Articles

Clanton Resigns From NCI.

January 12, 2007

FDA Panel urges Breast Implant Studies, Says Devices Should Remain Available

November 22, 1991

For NCI ; Scharff Succeeds Eagle At Einstein

September 25, 1987

Two New Organ Systems Working Groups to Be Considered By NCAB

October 4, 1985

NCI to set separate payline for R01s over $700,000.

February 13, 2004

NCI Director and Acting FDA Commissioner Andrew von Eschenbach Endorses Rep. E. Clay Shaw In Tour of Florida Congressman’s District. Von Eschenbach Praises Shaw’s “Leadership” In Seeking Funding For Research, Support of 2015 Goal.

February 3, 2006